[Expensive cancer drugs funding is undergoing turbulent times].
Hématologie clinique, hôpital d'Estaing, CHU de Clermont-Ferrand, 1, place Lucie-Aubrac, 63003 Clermont-Ferrand cedex, France. Electronic address: jobay@chu-clermontferrand.fr.
Jacques-Olivier
JO
Bay
Hématologie clinique, hôpital d'Estaing, CHU de Clermont-Ferrand, 1, place Lucie-Aubrac, 63003 Clermont-Ferrand cedex, France.
Gilles
G
L'Allemain
Hématologie clinique, hôpital d'Estaing, CHU de Clermont-Ferrand, 1, place Lucie-Aubrac, 63003 Clermont-Ferrand cedex, France.
Stéphane
S
Vignot
D000970:Antineoplastic Agents / Q000191:economics* / Q000600:supply & distribution; D016527:Drug Costs; D018954:Drugs, Essential / Q000191:economics*; D006801:Humans; D008495:Medical Oncology / Q000639:trends; D058990:Molecular Targeted Therapy / Q000191:economics*; D012051:Reimbursement Mechanisms
D000970:Antineoplastic Agents; D018954:Drugs, Essential